Green tea catechins in chemoprevention of cancer: A molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1)

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 1, 2009, Pages 287-295

  Artali, Roberto ^a   Beretta, Giangiacomo ^a   Morazzoni, Paolo ^b   Bombardelli, Ezio ^b   Meneghetti, Fiorella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INDENA S P A   (Italy)

Author keywords

Alkylating anti cancer drugs; EC 2.5.1.18); Epigallocatechingallate; Glutathione S transferases (GSTs; Green tea chemoprevention; Molecular docking; Phase II detoxifying enzymes

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; IFOSFAMIDE; MELPHALAN;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; DRUG CONFORMATION; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; EXPERIMENTAL MODEL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DOCKING; MOLECULAR MODEL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INTERACTION; TEA;

ANTINEOPLASTIC AGENTS, ALKYLATING; CATECHIN; CHEMOPREVENTION; COMPUTER SIMULATION; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; NEOPLASMS; TEA;

EID: 58949092756     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802177282     Document Type: Article

References (57)

1. Elsayad, YA and Sausville, EA (2001) Selected novel anticancer treatments targeting cell signaling proteins. Oncologist, 6, pp. 517-537.
2. Gottesman, MM and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem, 62, pp. 385-427.
3. Armstrong, RN (1997) Structure, catalytic machanism, and evolution of the glutathione transferase. Chem Res Toxicol, 10, pp. 2-18.
4. Eaton, DL and Bammler, TK (1999) Concise review of the glutathione S-transferase and their significance to toxicology. Toxicol Sci, 49, pp. 156-164.
5. Townsend, DM and Tew, KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene, 22, pp. 7369-7375.
6. O'Brien, ML and Tew, KD (1996) Glutathione and related enzymes in multidrug resistance. Eur J Cancer, 32, pp. 967-978.
7. Wilce, MCJ and Parker, MW (1994) Structure and function of glutathione S-transferases. Biochim Biophys Acta, pp. 1-18.
8. Anderson, C., Mosialou, E., Weinander, R. and Morgenstern, R. (1994) Enzymology of microsomal glutathione S-transferase. Adv Pharmacol, 27, pp. 19-35.
9. Jakobsson, PJ, Mancini, JA and Ford-Hutchinson, AW (1996) Identification and characterization of a novel human microsomal glutathione S-transferase with leukotriene C4 synthase activity and significant sequence identity to 5-lipoxygenase-activating protein and leukotriene C4 synthase. J Biol Chem, 271, pp. 22203-22210.
10. Pemble, SE, Wardle, AF and Taylor, JB (1996) Glutathione S-transferase class Kappa: Characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J, 319, pp. 749-754.
11. Mannervik, B., Lin, PA, Guthenberg, C., Jensson, H., Tahir, MK, Warholm, M. and Jornvall, H. (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: Correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA, 82, pp. 7202-7206.
12. Meyer, DJ, Coles, B., Pemble, SE, Gilmore, KS, Fraser, GM and Ketterer, B. (1991) Theta, a new class of glutathione transferases purified from rat and man. Biochem J, 274, pp. 409-414.
13. Meyer, DJ and Thomas, M. (1995) Characterization of rat spleen prostaglandin H D-isomerase as a sigma-class GSH transferase. Biochem J, 311, pp. 739-742.
14. Mannervik, B. (1985) The isoenzymes of glutathione transferase. Adv Enzymol, 57, pp. 357-417.
15. Watson, MA, Stewart, RK Smith, GB et al. (1998) Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19, pp. 275-280.
16. Michael, M. and Doherty, MM (2005) Tumoral drug metabolism: Overview and its implications for cancer therapy. J Clin Oncol, 23:1, pp. 205-229.
17. Coles, B. and Ketterer, B. (1990) The role of glutathione transferases in chemical carcinogenesis. CRC Crit Rev Biochem Mol Biol, 25, pp. 47-70.
18. Hayes, JD and Pulford, DJ (1995) The glutathione S-transferase supergene familyregulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. CRC Crit Rev Biochem Mol Biol, 30, pp. 445-600.
19. Tsuchida, S. and Sato, K. (1992) Glutathione transferases and cancer. CRC Crit Rev Biochem Mol Biol, 27, pp. 337-384.
20. Waxman, DJ (1990) Glutathione-S-transferases: Role in alkylating agent resistance and possible target for modulation chemotherapy-a review. Cancer Res, 50, pp. 6449-6454.
21. Montali, JA, Wheatley, JB and Schmidt, DE (1995) Comparison of glutathione S-transferase levels in predicting the efficacy of a novel alkylating agent. Cellular Pharmacol, 2, pp. 241-247.
22. Morgan, AS, Ciaccio, PJ, Tew, KD and Kauvar, LM (1996) Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother Pharmacol, 37, pp. 363-370.
23. Ohno, Y., Wakai, K., Genka, K., Ohmine, K., Kawamura, T., Tamakoshi, A., Aoki, R., Senda, M., Hayashi, Y. Nagao, K. et al. (1995) Tea consumption and lung cancer risk: A case-control study in Okinawa, Japan. Jpn J Cancer Res, 86, pp. 1027-1034.
24. Zhong, L., Goldberg, MS, Gao, YT, Hanley, JA, Parent, ME and Jin, F. (2001) A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology, 12, pp. 695-700.
25. Ji, BT, Chow, WH, Hsing, AW, McLaughlin, JK, Dai, Q., Gao, YT, Blot, WJ and Fraumeni Jr, JF (1997) Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer, 70, pp. 255-258.
26. Inoue, M., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Hirose, K., Hamajima, N. and Tominaga, S. (2001) Regular consumption of green tea and the risk of breast cancer recurrence: Follow-up study from the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett, 167, pp. 175-182.
27. Higdon, JV and Frei, B. (2003) Tea catechins and polyphenols: Health effects, metabolism and antioxidant functions. Crit Rev Food Sci Nutr, 43, pp. 89-143.
28. Lee, MJ, Maliakal, P., Chen, L., Meng, X., Bondoc, FY, Prabhu, S., Lambert, G., Mohr, S. and Yang, CS (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol Biomark Prev, 11, pp. 1025-1032.
29. Siddiqui, IA, Afaq, F., Adhami, VM, Ahmad, N. and Mukhtar, H. (2004) Antioxidants of the beverage tea in promotion of human health. Antioxid Redox Signal, 6, pp. 571-582.
30. Chai, PC, Long, LH and Halliwell, B. (2003) Contribution of hydrogen peroxide to the cytotoxicity of green tea and red wines. Biochem Biophys Res Commun, 304, pp. 650-654.
31. Khan, N., Afaq, F., Saleem, M., Ahmad, N. and Mukhtar, H. (2006) Targeting multiple signaling pathways by green tea polyphenol EGCG. Cancer Res, 66, pp. 2500-2505.
32. Chen, ZP, Schell, JB, Ho, CT and Chen, KY (1998) Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett, 129, pp. 173-179.
33. Gupta, D., Lis, CG, Birdsall, TC and Grutsch, JF (2005) The use of dietary supplements in a community hospital comprehensive cancer centre: Implications for conventional cancer care. Support Care Cancer, 13, pp. 912-919.
34. Molassiotis, A., Ozden, G. Platin, N. et al. (2006) Complementary and alternative medicine use in patients with head and neck cancer in Europe. Eur J Cancer Care (Engl), 15, pp. 19-24.
35. Molassiotis, A., Fernandez-Ortega, P. Pud, D. et al. (2005) Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med, 13, pp. 251-257.
36. Molassiotis, A., Scott, JA Kearney, N. et al. (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer, 14, pp. 260-267.
37. Block, KI, Koch, AC, Mead, MN, Tothy, PK, Newman, RA and Gyllenhaal, C. (2007) Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controller trials. Cancer Treat Rev, 33, pp. 407-418.
38. Yang, CS (1999) Tea and health. Nutrition, 15, pp. 946-949.
39. Ahmad, N. and Mukhtar, H. (1999) Green tea polyphenols and cancer: Biologic mechanisms and practical implications. Nutr Rev, 57, pp. 78-83.
40. Sherry Chow, HH, Hakim, IA, Vining, DR, Crowell, JA, Tome, ME, Ranger-Moore, J., Cordova, CA, Mikhael, DM, Briehl, MM and Alberts, DS (2007) Modulation of human glutathione S-transferase by polyphenon E intervention. Cancer Epidem Biomark, 16:8, pp. 1662-1666.
41. Pool-Zobel, B., Veeriah, S. and Bohmer, FD (2005) Modulation of xenobiotic metabolising enzymes by anticarcinogens-Focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colerectal carcinogenesis. Mutat Res, 591, pp. 74-92.
42. Talalay, P. (2000) Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors, 12, pp. 5-11.
43. Bravo, L. (1998) Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev, 56, pp. 317-333.
44. Morris, GM, Goodsell, DS, Halliday, RS, Huey, R., Hart, WE, Belew, RK and Olson, AJ (1998) Automated docking using a lamarkian genetic algorithm and an empirical binding free energy function. J Comp Chem, 19, pp. 1639-1662.
45. Pettersen, EF, Goddard, TD, Huang, CC, Couch, GS, Greenblatt, DM, Meng, EC and Ferrin, TE (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comp Chem, 25, pp. 1605-1612.
46. Frisch, MJ, Trucks, GW, Schlegel, HB, Scuseria, GE, Robb, MA, Cheeseman, JR, Montgomery, JA, Vreven, T., Kudin, KN Burant, JC et al. (2003) Gaussian 03. Revision A.1, Gaussian, Pittsburgh, PA
47. DeLano, WL (2002) The PyMOL molecular graphics system 2002, DeLano Scientific, San Carlos, CA
48. Sanner, MF (1999) Python: A programming language for software integration and development. J Mol Graphics Mod, 17, pp. 57-61.
49. Berendsen, HJC, Postma, JPM, van Gunsteren, WF, Hermans, J. and Pullman, B. (1981) Intermolecular forces, Reidel, Dordrecht
50. Jorgensen, WL, Chandrasekhar, J., Madura, J., Impey, RW and Klein, ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys, 79, pp. 926-933.
51. Miyamoto, S. and Kollman, PA (1992) SETTLE-an analytical version of the shake and rattle algorithm for rigid water models. J Comput Chem, 13, pp. 952-962.
52. Hess, B., Bekker, H., Berendsen, HJC and Fraaije, JGEM (1997) LINCS: A linear constraint solver for molecular simulations. J Comput Chem, 18, pp. 1463-1472.
53. Collaborative Computational Project, Number 4 (1994) The CCP4 suite: Programs for protein crystallography. Acta Cryst, pp. 760-763.
54. Dym, O., Xenarios, I., Ke, H. and Colicelli, J. (2002) Molecular docking of competitive phosphodiesterase inhibitors. Mol Pharmacol, 61, pp. 20-25.
55. Kolm, RH, Sroga, GE and Mannervik, B. (1992) Participation of the phenolic hydroxyl group of Tyr-8 in the catalytic mechanism of human glutathione transferase P1-1. Biochem J, 285, pp. 537-540.
56. Kong, KH, Nishida, M., Inoue, H. and Takahashi, K. (1992) Tyrosine-7 is an essential residue for the catalytic activity of human class PI glutathione S-transferase: Chemical modification and site-directed mutagenesis studies. Biochem Biophys Res Commun, 182, pp. 1122-1129.
57. Oakley, J., Lo Bello, M, Battistoni, A., Ricci, G., Rossjohn, J., Villar, HO and Parker, MW (1997) The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution. J Mol Biol, 274, pp. 84-100.